文献速递乳腺癌

MAITA随机试验:数字乳腺断层摄影与数字乳腺摄影检出或漏诊癌症的组织学亚型与受体特征

Histological subtype and receptor characteristics of cancers detected or missed by digital mammography and tomosynthesis: Results from MAITA randomized trials.
PubMed 文献 · Eur J Cancer · 2026-03-19

该研究汇总MAITA联盟两项随机试验数据,比较DBT+DM与单独DM筛查检出的癌症组织学特征。基线筛查100743名女性(664例癌症),后续轮次随访82938名女性(550例癌症)。DBT在首轮检出率提高50%,但间隔癌发生率相似(IRR 0.95),后续轮次检出降低14%但总癌症仍 excess 16%(IRR 1.16)。DBT主要检出原本会在后续轮次表现为较大肿瘤且预后较好的癌症。

要点

  • DBT首轮检出率较DM提高50%,间隔癌发生率无显著差异。
  • DBT对大型肿瘤、3级、HER2阳性及三阴性癌的检出增加不明显。
  • DBT主要检出预后较好的肿瘤,可能减少后续轮次大型肿瘤出现。

核心结论

  • DBT可能检出那些原本会在后续筛查轮次表现为较大肿瘤的癌症,尤其是具有内在良好预后特征的肿瘤。

研究设计与样本

  • 汇总MAITA联盟两项随机试验数据,基线筛查100743名女性(664例癌症),随机分配至DBT+DM或单独DM。
  • 后续轮次随访82938名女性(550例癌症),均使用单独DM筛查。
  • 比较DBT+DM与单独DM筛查检出的癌症组织学特征,除间隔癌和累积发生率外未进行统计检验。

主要发现

  • 首轮筛查中DBT组检出率比DM组高50%。
  • 两组间隔癌总体发生率相似(IRR 0.95,95%CI 0.69-1.32)。
  • 后续轮次DBT组检出率低14%,但总体癌症仍 excess 16%(IRR 1.16,95%CI 1.04-1.30)。
  • DBT初始检出增加在大多数肿瘤类型中一致,但大型肿瘤(≥20 mm)、3级、HER2阳性和三阴性癌除外。
  • 第二轮后检出减少在大肿瘤和淋巴结阳性疾病中明显,但在侵袭性亚型(激素受体阴性、HER2阳性、Ki-67阳性、三阴性)中不明显。

临床怎么用

  • DBT筛查可能有助于提前检出预后较好的肿瘤,减少后续轮次大型肿瘤的出现。
  • 对于侵袭性亚型(如三阴性、HER2阳性),DBT的早期检出优势有限,需结合其他手段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Screening with digital breast tomosynthesis (DBT) detects more cancers than with digital mammography (DM), but has small effect, if any, on interval cancer incidence. METHODS: Data were pooled from two randomized trials within the MAITA Consortium, including 100743 women (664 cancers) screened at baseline and 82938 women (550 cancers) followed for cumulative incidence at subsequent round. At baseline, women were randomized to DBT+DM or DM alone; subsequent round used DM only. We compare the histological characteristics of cancers detected in women screened with DBT+DM versus DM alone, both at recruitment and after a negative screening result. No statistical tests are applied, except for interval cancers and cumulative incidence. FINDINGS: At the first round, the detection rate was 50% higher in the DBT arm compared to the DM arm. The overall incidence of interval cancers was similar in the two arms (IRR 0.95 (0.69-1.32)). At the subsequent round, the detection was 14% lower in the DBT arm, but an overall residual 16% excess of cancers remained (IRR 1.16 (1.04-1.30)). The initial increase in detection with DBT was consistent across most tumor types, except for large tumors (≥20 mm), grade 3, HER2-positive and triple-negative cancers. The reduction in detection after the second round was appreciable for large tumors and node-positive disease, but not for aggressive subtypes (hormone receptors (estrogen- and progesterone)-negative, HER2-positive, Ki-67 positive, triple-negative). INTERPRETATION: DBT likely detects tumours that would have presented as larger tumours in later screening rounds, particularly those with intrinsically favorable prognostic features.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Mancuso P, Ragazzi M, Castellano I, et al. Histological subtype and receptor characteristics of cancers detected or missed by digital mammography and tomosynthesis: Results from MAITA randomized trials. Eur J Cancer. 2026. PMID: 41895001. doi:10.1016/j.ejca.2026.116687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。